Scleroderma lung disease

Jérôme Le Pavec, David Launay, Stephen Mathai, Paul M Hassoun, Marc Humbert

Research output: Contribution to journalArticle

Abstract

Pulmonary involvement is second in frequency only to esophageal involvement as a visceral complication of systemic sclerosis (SSc) and has surpassed renal involvement as the most common cause of death. Interstitial lung disease and pulmonary vascular disease, particularly pulmonary arterial hypertension, are the most commonly encountered types of lung involvement. Chronic aspiration, airway disease, neuromuscular weakness, extrinsic pulmonary restrictive pathology, pleural effusions, pneumothorax, and lung cancer cause clinically significant disease and occur commonly enough to be routinely considered in the assessment of the SSc patient with respiratory symptoms. Affected patients have a significantly worse prognosis than patients with SSc who are free of pulmonary involvement.

Original languageEnglish (US)
Pages (from-to)104-116
Number of pages13
JournalClinical Reviews in Allergy and Immunology
Volume40
Issue number2
DOIs
StatePublished - Apr 2011

Fingerprint

Lung Diseases
Systemic Scleroderma
Lung
Neuromuscular Diseases
Interstitial Lung Diseases
Pneumothorax
Pleural Effusion
Vascular Diseases
Pulmonary Hypertension
Cause of Death
Lung Neoplasms
Pathology
Kidney

Keywords

  • Interstitial lung disease
  • Pulmonary arterial hypertension
  • Scleroderma
  • Scleroderma lung disease
  • Scleroderma-related pulmonary arterial hypertension

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Scleroderma lung disease. / Le Pavec, Jérôme; Launay, David; Mathai, Stephen; Hassoun, Paul M; Humbert, Marc.

In: Clinical Reviews in Allergy and Immunology, Vol. 40, No. 2, 04.2011, p. 104-116.

Research output: Contribution to journalArticle

Le Pavec, Jérôme ; Launay, David ; Mathai, Stephen ; Hassoun, Paul M ; Humbert, Marc. / Scleroderma lung disease. In: Clinical Reviews in Allergy and Immunology. 2011 ; Vol. 40, No. 2. pp. 104-116.
@article{459b0cedd37244ab96377dcff5094bc2,
title = "Scleroderma lung disease",
abstract = "Pulmonary involvement is second in frequency only to esophageal involvement as a visceral complication of systemic sclerosis (SSc) and has surpassed renal involvement as the most common cause of death. Interstitial lung disease and pulmonary vascular disease, particularly pulmonary arterial hypertension, are the most commonly encountered types of lung involvement. Chronic aspiration, airway disease, neuromuscular weakness, extrinsic pulmonary restrictive pathology, pleural effusions, pneumothorax, and lung cancer cause clinically significant disease and occur commonly enough to be routinely considered in the assessment of the SSc patient with respiratory symptoms. Affected patients have a significantly worse prognosis than patients with SSc who are free of pulmonary involvement.",
keywords = "Interstitial lung disease, Pulmonary arterial hypertension, Scleroderma, Scleroderma lung disease, Scleroderma-related pulmonary arterial hypertension",
author = "{Le Pavec}, J{\'e}r{\^o}me and David Launay and Stephen Mathai and Hassoun, {Paul M} and Marc Humbert",
year = "2011",
month = "4",
doi = "10.1007/s12016-009-8194-2",
language = "English (US)",
volume = "40",
pages = "104--116",
journal = "Clinical Reviews in Allergy and Immunology",
issn = "1080-0549",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - Scleroderma lung disease

AU - Le Pavec, Jérôme

AU - Launay, David

AU - Mathai, Stephen

AU - Hassoun, Paul M

AU - Humbert, Marc

PY - 2011/4

Y1 - 2011/4

N2 - Pulmonary involvement is second in frequency only to esophageal involvement as a visceral complication of systemic sclerosis (SSc) and has surpassed renal involvement as the most common cause of death. Interstitial lung disease and pulmonary vascular disease, particularly pulmonary arterial hypertension, are the most commonly encountered types of lung involvement. Chronic aspiration, airway disease, neuromuscular weakness, extrinsic pulmonary restrictive pathology, pleural effusions, pneumothorax, and lung cancer cause clinically significant disease and occur commonly enough to be routinely considered in the assessment of the SSc patient with respiratory symptoms. Affected patients have a significantly worse prognosis than patients with SSc who are free of pulmonary involvement.

AB - Pulmonary involvement is second in frequency only to esophageal involvement as a visceral complication of systemic sclerosis (SSc) and has surpassed renal involvement as the most common cause of death. Interstitial lung disease and pulmonary vascular disease, particularly pulmonary arterial hypertension, are the most commonly encountered types of lung involvement. Chronic aspiration, airway disease, neuromuscular weakness, extrinsic pulmonary restrictive pathology, pleural effusions, pneumothorax, and lung cancer cause clinically significant disease and occur commonly enough to be routinely considered in the assessment of the SSc patient with respiratory symptoms. Affected patients have a significantly worse prognosis than patients with SSc who are free of pulmonary involvement.

KW - Interstitial lung disease

KW - Pulmonary arterial hypertension

KW - Scleroderma

KW - Scleroderma lung disease

KW - Scleroderma-related pulmonary arterial hypertension

UR - http://www.scopus.com/inward/record.url?scp=79951681966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951681966&partnerID=8YFLogxK

U2 - 10.1007/s12016-009-8194-2

DO - 10.1007/s12016-009-8194-2

M3 - Article

VL - 40

SP - 104

EP - 116

JO - Clinical Reviews in Allergy and Immunology

JF - Clinical Reviews in Allergy and Immunology

SN - 1080-0549

IS - 2

ER -